Seaport Therapeutics, Inc.
SPTX
$24.22
$0.512.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 713.85% | 8.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 267.14% | 66.67% | |||
| Operating Income | -267.14% | -66.67% | |||
| Income Before Tax | -317.25% | -90.08% | |||
| Income Tax Expenses | 87.31% | 1,574.19% | |||
| Earnings from Continuing Operations | -315.20% | -93.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -315.20% | -93.58% | |||
| EBIT | -267.14% | -66.67% | |||
| EBITDA | -267.84% | -66.88% | |||
| EPS Basic | 72.23% | -83.10% | |||
| Normalized Basic EPS | 72.09% | -79.79% | |||
| EPS Diluted | 72.23% | -83.10% | |||
| Normalized Diluted EPS | 72.09% | -79.79% | |||
| Average Basic Shares Outstanding | 1,395.09% | 5.73% | |||
| Average Diluted Shares Outstanding | 1,395.09% | 5.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||